Synthesis, Characterization and Antibacterial Activities of Polydentate Schiff Bases, Based on Salicylaldehyde

Three Schiff bases L1, L2 and L3 were synthesized by condensing salicylaldehyde with 4-aminoantipyrine, ethylendiamine and 2-aminophenol respectively and subsequently characterized by various physicochemical investigations. All the three compounds were screened for their In-vitro antibacterial activity against two gram positive bacteria, Staphylococcus aureus (S.A), Staphylococcus epidermidis (S.E) and two gram negative bacteria Klebsiella pneumoniae (K.P) and Pseudomonas aeruginosa (P.A) by agar diffusion method. On comparing the results obtained with the activity of commercially available antibiotics such as Ciprofloxacin and Chloramphenicol, the newly synthesized compounds showed comparable antibacterial activities. The solvent methanol exhibit activity against all bacterial species with IZs ranging from 8 ± 0.25 to 17 ± 0.29 mm while the standard antibiotics Ciprofloxacin and Chloramphenicol exhibited an activities with IZs varying from 21.3 ± 0.31 to 28.3 ± 0.32 and 26.3 ± 0.24 mm to 32.3 ± 0.23 mm, respectively. However, the newly synthesized Schiff bases L1, L2 and L3 showed IZs ranging from 7.4 ± 0.23 to 32.5 ± 0.14, 3 ± 0.57 to 12 ± 0.28 and 10 ± 0.20 to 32 ± 0.36 respectively. Among the Schiff bases, L3 showed the activity (32 ± 0.36) against S.E and P.A which is higher than the activity of standard antibiotics Ciprofloxacin and Chloramphenicol against the same bacterial strains. The results obtained revealed that all the synthesized Schiff bases exhibit appreciable antibacterial activity against all the bacteria species which potentially makes them, to apply as wide range antibacterial drugs, after further in-vivo cytotoxicity investigations. Their activity can also be further modified by changing the functionality of precursors for Schiff base condensation.